Mapatumumab (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Mapatumumab" in Italian language version.

Last modified: 20:27:00, 30 August 2025 (UTC)

Ref.Un. Ref.Website

Global rank Italian rank

44archive.today

28^th place

193^rd place

low place

low place

4,430^th place

4,040^th place

612^th place

14^th place

2^nd place

3^rd place

5^th place

6^th place

11web.archive.org

1^st place

1^st place

ama-assn.org (Global: 4,430^th place; Italian: 4,040^th place)

(EN) Mapatumumab (DOC), su American Medical Association. URL consultato il 6 luglio 2025.

archive.today (Global: 28^th place; Italian: 193^rd place)

(EN) Human Genome Sciences reports interim results of phase 1B clinical trials of HGS-ETR1 in combination with chemotherapy in patients with advanced solid tumors, su Human Genome Sciences. URL consultato il 6 luglio 2025.
(EN) Human Genome Sciences reports results of phase 2 clinical trial of HGS-ETR1 in patients with non-small-cell lung cancer, su Human Genome Sciences. URL consultato il 6 luglio 2025.
(EN) Human Genome Sciences reports results of phase 2 clinical trial of HGS-ETR1 in patients with advanced colorectal cancer, su Human Genome Sciences. URL consultato il 6 luglio 2025.
(EN) Human Genome Sciences reports interim results of phase 1B clinical trials of HGS-ETR1 in combination with chemotherapy in patients with advanced solid tumors, su Human Genome Sciences. URL consultato il 6 luglio 2025.

doi.org (Global: 2^nd place; Italian: 3^rd place)

dx.doi.org

(EN) Moretto P, Hotte SJ, Targeting apoptosis: preclinical and early clinical experience with mapatumumab, an agonist monoclonal antibody targeting TRAIL-R1, in Expert Opinion on Investigational Drugs, vol. 18, n. 3, marzo 2009, pp. 311-325, DOI:10.1517/13543780902752463, PMID 19243282.

hgsi.com (Global: low place; Italian: low place)

(EN) Human Genome Sciences reports results of ongoing phase 1 clinical trials of HGS-ETR1 in patients with advanced cancers, su Human Genome Sciences. URL consultato il 6 luglio 2025.
(EN) Human Genome Sciences reports interim results of phase 1B clinical trials of HGS-ETR1 in combination with chemotherapy in patients with advanced solid tumors, su Human Genome Sciences. URL consultato il 6 luglio 2025.

nih.gov (Global: 5^th place; Italian: 6^th place)

ncbi.nlm.nih.gov

(EN) Moretto P, Hotte SJ, Targeting apoptosis: preclinical and early clinical experience with mapatumumab, an agonist monoclonal antibody targeting TRAIL-R1, in Expert Opinion on Investigational Drugs, vol. 18, n. 3, marzo 2009, pp. 311-325, DOI:10.1517/13543780902752463, PMID 19243282.

oadoi.org (Global: 612^th place; Italian: 14^th place)

(EN) Moretto P, Hotte SJ, Targeting apoptosis: preclinical and early clinical experience with mapatumumab, an agonist monoclonal antibody targeting TRAIL-R1, in Expert Opinion on Investigational Drugs, vol. 18, n. 3, marzo 2009, pp. 311-325, DOI:10.1517/13543780902752463, PMID 19243282.

web.archive.org (Global: 1^st place; Italian: 1^st place)

(EN) Human Genome Sciences says cancer drug fails study, su Bloomberg, 9 giugno 2010. URL consultato il 6 luglio 2025 (archiviato dall'url originale il 24 ottobre 2012).